Article Versions Notes

Omori M, Shibuya T, Ishino H, Fukuo Y, Odakura R, Koma M, Maruyama T, Ito K, Haraikawa M, Nomura K, et al. Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan. Biomedicines. 2024; 12(5):1119. https://doi.org/10.3390/biomedicines12051119

Omori, Masashi, Tomoyoshi Shibuya, Hirotaka Ishino, Yuka Fukuo, Rina Odakura, Masao Koma, Takafumi Maruyama, Kentaro Ito, Mayuko Haraikawa, Kei Nomura, and et al. 2024. "Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan" Biomedicines 12, no. 5: 1119. https://doi.org/10.3390/biomedicines12051119

Omori, M., Shibuya, T., Ishino, H., Fukuo, Y., Odakura, R., Koma, M., Maruyama, T., Ito, K., Haraikawa, M., Nomura, K., Yano, S., Nomura, O., Ishikawa, D., Hojo, M., Osada, T., & Nagahara, A. (2024). Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan. Biomedicines, 12(5), 1119. https://doi.org/10.3390/biomedicines12051119